Showing 8231-8240 of 10256 results for "".
- Dr. Adam Friedman Named Chair of Dermatology at George Washington Universityhttps://practicaldermatology.com/news/dr-adam-friedman-named-chair-of-dermatology-at-george-washington-university/2460718/Adam Friedman, MD has been
- COVID-19, the Stock Market, and Dermatologyhttps://practicaldermatology.com/news/covid-19-the-stock-market-and-dermatology/2460688/By Amylee Martin, BS, Akshitha Thatiparthi, BS, Jeffrey Liu, BS, Jashin J. Wu, MD Novel coronavirus, COVID-19, is not only a major public health threat but has also impacted the economy. Due to the pandemic, experts predict a 0.5% decrease in t
- FDA Approves Galderma's Restylane Defyne for Chin Augmentationhttps://practicaldermatology.com/news/fda-approves-galdermas-restylane-defyne-for-chin-augmentation/2460676/The U.S. Food and Drug Administration (FDA) has approved Restylane Defyne for the augmentation and correction of mild to moderate chin retrusion in adults over the age of 21. Restylane Defyne is a hyaluronic acid (HA) dermal filler that was first approved in 201
- Arcutis Moves Another Candidate Into Phase 3 Trialshttps://practicaldermatology.com/news/arcutis-moves-another-candidate-into-phase-3-trials/2460664/Roughly a week after announcing plans to initiate Phase 3 clinical trials for topical roflumilast cream (ARQ-151) in the treatment of atopic dermatitis (AD),
- EADV Congress Update: Insights on Psoriasis, AD, UV Protection, COVID-19, and Morehttps://practicaldermatology.com/news/eadv-congress-update-insights-on-psoriasis-ad-uv-protection-covid-19-and-more/2460588/From updates on investigational treatments for dermatologic diseases to emerging healthcare trends, data from the 29th EADV Congress, EADV Virtual suggest new directions in patient care. Psoriasis: Results from the phas
- Call for Entries: Hacking Dermatology 2020 Innovation Challenge to Focus on Dermatologic Challenges in Skin of Colorhttps://practicaldermatology.com/news/call-for-entries-hacking-dermatology-2020-innovation-challenge-to-focus-on-dermatologic-challenges-in-skin-of-color/2460562/Applications are now being accepted for
- EB Research Partnership and EB Research Foundation Form Largest Global Organization Advancing EB Researchhttps://practicaldermatology.com/news/eb-research-partnership-and-eb-research-foundation-form-largest-global-organization-advancing-eb-research/2460559/EB Research Partnership (EBRP), based in New York, and EB Research Foundation (EBRF) of Australia are uniting to become the largest global organization focused on funding research to discover treatments and cures for Epidermolysis Bullosa (EB). As the two leading organiza
- TARGET-DERM Real-World Study Expandshttps://practicaldermatology.com/news/target-derm-real-world-study-expands/2460550/Target RWE is expanding its active longitudinal dermatology registry, TARGET-DERM (
- Arcutis to Accelerate Program for ARQ-151 for Atopic Dermatitishttps://practicaldermatology.com/news/arcutis-to-accelerate-program-for-arq-151-for-atopic-dermatitis/2460520/Arcutis Biotherapeutics, Inc. plans to advance its program to develop ARQ-151 (topical roflumilast cream) for the treatment of atopic dermatitis into Phase 3 clinical trials without conducting the previously planned Phase 2b atopic dermatitis trial. The decision follows an End
- Galderma Gives Back: Company Donates 1,200 Backpacks Filled with School Supplies to Northwest ISD Studentshttps://practicaldermatology.com/news/galderma-gives-back-company-donates-1200-backpacks-filled-with-school-supplies-to-northwest-isd-students/2460495/For the fifth consecutive year, Galderma donated backpacks filled with school supplies to Northwest Independent School District (NISD) students. This year, Galderma donated 1,200 backpacks for students in grades Kindergarten through 12, for a total of 6,105 backpacks donated since 2016.